BridgeBio Pharma, Inc.
BridgeBio Pharma is a clinical-stage biopharmaceutical company focused on genetic diseases with minimal political/regulatory footprint and no active lobbying presence.
BusinessWhat BBIO does
BridgeBio develops therapies for severe genetic diseases through its portfolio of subsidiary companies. Revenue is primarily from research collaborations and milestone payments rather than approved drug sales. The company operates as a biotech holding company with multiple pipeline programs in early-to-mid clinical development.
12 months past · 3 months futureBBIO activity timeline
Executive Branch ConflictsBBIO held by Trump-administration officials
Lifetime Government AwardsBBIO federal contracts
BBIO doesn't hold direct federal contracts.
Verified via USASpending.gov: $0 reported in direct prime-contract awards. Companies in this position typically sell federal services indirectly through prime contractors and integrators (e.g., Lockheed Martin, Booz Allen, Microsoft Azure) or through commercial channels that don't appear in USASpending data.
Smart Money · 13F HoldingsHedge funds holding BBIO
Politicians Trading BBIOMembers of Congress with recent BBIO positions
Congressional TradesWho in Congress is trading BBIO
Corporate Insiders · Form 4What CEOs, CFOs, and directors are doing with their own stock
No Form 4 activity recorded in the last 180 days.
Bills Affecting BBIOLive legislation impacting this stock
Political ProfileWhere BBIO sits in Washington
Clinical-stage biotech with no lobbying activity and minimal regulatory exposure. Stock movement driven by clinical trial data and financing events, not policy.
Regulatory ExposureThreats & opportunities
Regulatory threats
- FDA clinical trial requirements tightening
- rare disease reimbursement pressure
Regulatory opportunities
- Orphan drug tax credit expansion
- accelerated approval pathway utilization
Live signals + predictions for BBIO — for Founders
The free page above gives you the public record. Members see the real-time intelligence layer on top of it:
- Live 7-layer signal scores when Congress trades BBIO
- Bill Pass Index v2 odds for every bill on the watch list
- Iron Triangle alerts (committee × donor × trade)
- SEC Form 4 cluster detection (CEO + CFO + director buys)
- Whale-Opportunity expected-value ranking
- Custom watchlist alerts via email + Discord